Lanreotide Acetate is a drug used in the control and prevention of glycemia and hypoglycemic brain damage without surgery in patients diagnosed with congenital hyperinsulinism. It improves outcomes in patients suffering from acromegalyresulting from invasive pituitary macroadenoma. Melting Point: 172-175C (dec.) Solubility: DMSO, Methanol
Molecular Weight:
1096.326005
Form:
Supplied as a White Solid
CAS Number:
[127984-74-1]
* VAT and and shipping costs not included. Errors and price changes excepted